CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
about
Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology.Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinomaUtility of serum CA19-9 levels in the diagnosis of pancreatic ductal adenocarcinoma in an endoscopic ultrasound referral population.Morbidity and mortality of pancreatic tumors undergoing surgical treatmentThe Role of CA19-9 in Predicting Tumour Resectability in Carcinoma Head of PancreasThe clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases.Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretationBiomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreasACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance.High-throughput and high-sensitivity quantitative analysis of serum unsaturated fatty acids by chip-based nanoelectrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry: early stage diagnostic biomarkers of pancreatic cancer
P2860
Q34405197-C7231109-4F46-4E49-B6A4-E9334BE3AA64Q34483897-283A4BB8-A1FA-4E1D-928B-99A6C57C4585Q36025215-7C94F858-56B8-4051-A013-B7744A785CEDQ36549824-1613E01B-7B70-4C77-8C90-51382E8C1D09Q36831137-7B2A1ED6-91BF-463E-9ABC-A0BCA46FBF52Q36937026-032FB0F0-0CDA-425F-AC1D-C91CCE825CDBQ37011364-70FEE0EB-6C20-4BB6-9CE0-3868018D340EQ38129331-3EF8F3AB-2FF2-41EB-8E3A-FD8B84006E16Q38682057-760CCC41-B578-49DC-AE32-CC9C7B63A1DFQ41440976-EFF5C70E-963F-4057-B638-8060579E014EQ43461210-11C64978-29FA-44EC-A68E-C925584ABEFDQ50334993-41C08562-C25F-4D20-8050-E6C8850EDB09Q51521398-964BF0C3-1200-4DC4-BA02-B9EE3A0D6BAD
P2860
CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2011
@uk
name
CA 19–9 in pancreatic cancer: ...... suspicion of pancreatic cancer
@en
CA 19–9 in pancreatic cancer: ...... suspicion of pancreatic cancer
@nl
type
label
CA 19–9 in pancreatic cancer: ...... suspicion of pancreatic cancer
@en
CA 19–9 in pancreatic cancer: ...... suspicion of pancreatic cancer
@nl
prefLabel
CA 19–9 in pancreatic cancer: ...... suspicion of pancreatic cancer
@en
CA 19–9 in pancreatic cancer: ...... suspicion of pancreatic cancer
@nl
P2093
P2860
P1433
P1476
CA 19–9 in pancreatic cancer: ...... suspicion of pancreatic cancer
@en
P2093
Carles Conill
Joana Ferrer
Jose M. Auge
Jose M. Escudero
Laura Visa
Laureano Fernandez-Cruz
Miguel A. Lopez-Boado
Rafael Molina
Salvador Navarro
Victor Molina
P2860
P2888
P304
P356
10.1007/S13277-011-0297-8
P577
2011-12-29T00:00:00Z